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Abstract 
Background: Attenuation of the P-wave amplitudes in patients with peripheral edema (PERED) 
has been recently reported, with P-waves regaining some of their amplitude in patients, who 
subsequently experienced amelioration of their PERED. Changes in the P-waves correlated with 
the corresponding alterations in the QRS complexes. Also since amplitudes and durations of 
QRS complexes changed in parallel in patients with PERED, it was hypothesized that similar 
changes in the P-wave amplitudes, mean P-wave duration (P-du-mean), and P-wave dispersion 
(P-d),   would   occur   in   such   patients.                                                          
Methods: Measurements of P-wave amplitude, P-du-mean and P-d in patients who developed, or 
experienced   alleviation,   of   PERED,   were   carried   out   and   analyzed.                      
Results:  Although P-wave amplitudes and P-wave areas decreased with development of PERED 
(N = 16), and increased with its amelioration (N = 6), P-dur-mean before PERED was 66.8±14.5 
ms, and at peak weight gain it was 65.2±11.9 ms, p = 0.66; also at peak weight gain and 
subsequent lowest weight, in the patients who lost weight, it was 66.5±9.9 ms and 72.3±12.0 ms, 
respectively, p = 0.38. Similarly the P-d prior to PERED was 62.3±25.2 ms, and at peak weight 
gain it was 74.3±29.3 ms, p = 0.09; also at peak weight and subsequent lowest weight, in the 
patients who lost weight, it was 58.8±34.2 ms, and 61.3±13.6 ms, respectively, p = 0.87.    
Conclusions:   P-du-mean and P-d did not change in patients who developed PERED; their 
stability is attributed to the offsetting of the electrophysiologically-mediated real changes, by 
opposite apparent changes, imparted by PERED.
Key Words:  Electrocardiology, electrophysiology, P-wave duration, P-wave dispersion, low 
voltage ECG, peripheral edema, hemodialysis, congestive heart failure
Introduction
               Attenuation of the amplitude of P-waves in patients developing peripheral edema 
(PERED), similar changes in the respective QRS complexes, and increase in weight, with good 
inter-correlations, have been previously reported.1 Since duration of QRS complexes changed in 
parallel with amplitude of QRS complexes in the same patients,2 it was hypothesized that similar 
changes in the P-wave duration, P-wave dispersion (P-d), and amplitude of P-waves would occur 
in such patients with PERED. Previously, P-waves were measured manually and reported as 
sums of the amplitude of all 12 ECG leads in mm (ΣP).1 Automated measurements3 on the same 
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ECGs of an array of additional P-wave variables, not included in the first report,1  e.g., mean P-
wave duration (P-du-mean), and P-d, were used in the present study. The  last  2  have  been 
investigated intensely in the past, and increased values have been found in patients with cardiac 
and other pathology.4-23  Importantly, increased P-du-mean and P-d have been shown to be 
predictive of atrial fibrillation (AF) in general, long term vs. short term AF, and AF after 
cardiothoracic surgery, mostly coronary bypass grafting.4-6,8,11,13,15-23 Increase in P-du-mean is 
felt to be reflective of intra-atrial conduction delay, and thus it signifies an electropysiological 
disturbance. Measurements of P-du-mean in all above studies were carried out manually 
(employing all leads or selective ones, e.g., lead II), or via automated computer algorithms. Also 
P duration assessed by signal averaged ECG has been implemented successfully for the 
prediction of post-operative AF.24-27 Moreover decrease in the P-du-mean has been documented 
in patients with congestive heart failure (CHF), responding to diuresis28 or after nitroprusside 
infusion,29  and increase in patients undergoing hemodialysis (HD).30,31  It is intriguing that 
alleviation of fluid overload in patients with CHF and after HD28,30,31 led to divergent effects on 
the P-du-mean. The objective of the present study was to evaluate several P-wave variables 
(mainly P-du-mean and P-d) in patients with PERED, and its subsequent partial alleviation. 
Material and methods                                                                                                     
Study patients                                                                                                       
            The 28 patients with and 28 "controls" without PERED, employed in a previous report,1 
were considered herein; only 16 of the PERED patients with sinus rhythm on admission and at 
peak weight gain (47.5±29.6 lbs, 32.6±22.2%) were studied; 12 patients underwent pacemaking, 
or suffered AF. Six patients with PERED, who lost subsequently weight (48.8±26.6 lbs, 
21.5±11.4%), were re-studied. The PERED patients presented with hypertension, pneumonia, 
exacerbated chronic obstructive lung disease, respiratory arrest, respiratory failure, acute 
respiratory distress syndrome, sepsis, anoxic encephalopathy, or a combination of ≥2 of the 
above, in addition to their chronic conditions like diabetes mellitus, coronary artery disease, 
stroke,   tuberculosis,   and   other   miscellaneous,   renal,   and   gastrointestinal   afflictions.32 
            From the 28 "controls", 20 were included, since 8 had pacemaking/AF, and presented 
with various cardiovascular and other illnesses (peumonia, respiratory arrest, respiratory failure, 
chronic obstructive lung disease, CHF, or a combination of ≥2 of the above), requiring 
admission,32 and had ECG measurements on admission and at discharge.                        
Study variables and measurements                                                                             
            Details on patients and study design can be found elsewhere;32  variables used herein 
included the P-du-mean, maximum P-du (P-max), minimum P-du (P-min), the standard 
deviation of the P-du from all 12 ECG leads (P-du-SD),33 all in ms, the mean P-wave area in 
"Ashman" units (P-area-mean) (1 Ashman unit = an area of 1.0 mm2),3,34 the P-d (P-max  -  P-
min, using all 12 ECG leads) in ms, the mean P-amp in mm (P-amp-mean), and the horizontal 
axis of the P-waves (P-horiz-axis) in degrees. Data on the P-wave frontal axis (P-fro-axis), ΣP in 
mm, P-R intervals, and heart rates has been reported previously.1 The P-du-mean and mean P-
area were calculated by summing the individual such P-wave values from all 12 ECG leads, 
provided by the automated program (HP, now Philips M1700A PageWriter model)3 (Figure 1) 
and  dividing  by  12.  This  automated  measurement  and  interpretation  program  has  been 
previously validated.35,36 The software could measure P-wave duration in all 12 leads in 31 of 38 
instances (16 from admission, 16 from the time of peak weight, and 6 from the time of lowest 
weight) (81.6%), which represented all 16 patients on admission, 9 of the 16 patients at the time 
of the peak weight, and all 6 patients, at the time of subsequent, to the time of the peak lowest 
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weight, for the patients who lost weight. In the other 7 patients the software could measure only 
10 leads (excluding V5 and V6) in patient #1, 11 leads (excluding III) in patients #4 and #13, 11 
leads (excluding I) in patient #5, 7 leads (excluding aVL and V3-V6) in patient #11, 8 leads 
(excluding aVL and V4-V6) in patient #23, and 7 leads (excluding I, aVL and V4-V6) in patient 
#26. For calculation of the P-du-mean in instances with measurements of fewer than 12 leads the 
sums of the values of the P-wave durations, were divided by the number of the leads with 
successful measurement. Values of ΣP1 (manual measurements) were used for comparisons with 
the mean P-wave amplitude (P-amp-mean), which was calculated as the sum of the values of all 
ECG   leads,   provided   by   the   automated   ECG   program,   divided   by   12.   For   all   above 
measurements data were obtained or calculated by taking in consideration the printed form of the 
"Extended Measurement Report" generated by the automated program,3  part of which is 
reproduced in the upper panel of Figure 1. Data acquisition was the same for all patients at 
baseline, the time of the peak weight gain, and the time of subsequent lowest weight (for patients 
who lost weight). The automated system does not generate records of the ECG measurements, 
with caliper markings indicating the onset and offset of P-waves, used in the measurement of P-
wave duration, but only provides the numerical value of the measurements. The automated 
measurements of the P-wave are part of the overall ECG measurements of the HP ECG Analysis 
Program, and it is based on simultaneous 12-lead acquisition of the ECG.  Calibration of the 
ECG recordings was 10 mm = 1.0 mV, and the paper speed was 25 mm/sec. Automated 
measurements of the variables provided inclusion of unbiased data for analysis.  Figure 2 
illustrates the minuscule amplitude and duration of P-waves particularly with PERED, which 
makes it impossible to measure manually, and explains the necessity of using automation in 
acquisition of parameters displayed in  Figure 1. Serum K+, Ca++, Mg++, and HCO3  were 
monitored during the study.
Figure 1:   Reproduction of the pertinent portion of the "Extended measurement Report" 
provided by the automated measurement program3, with the values of measurements for all 12- 
ECG leads, and the calculated variables based on such measurements. 
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Figure 2: Standard ECGs of patient #13 on admission (A), and after he gained 41.6 lbs (18 9 
Kg) (28.9 %) in the process of developing PERED; P-waves in leads II, V1, and V2 before 
PERED (*), and after PERED (+). 
Statistical   analysis                                                                        
            Continuous data are presented as mean±SD, and were analyzed with the unpaired and 
paired t tests, as indicated. The Levene test37 was used in conjunction with the unpaired t test to 
decide whether the population variances for the subgroups of patients with PERED and the 
"controls" were equal or not, and thus the "pooled variance estimate" or the "separate variance 
estimate" should be employed respectively for the assessment of the significance level. Nominal 
data were analyzed by the chi square test, and associations between continuous data were 
evaluated by  Pearson correlation  analysis.  All statistical operations were 2-tailed.38  The 
SPSS/PC+ 4.0.1 statistical package36  was used, and a p<0.05 was taken as statistically 
significant.
Results  
Patients with PERED vs. "controls"                                                                             
     
            No difference in age, sex distribution, ΣP, P-fro-axis, P-horiz-axis (p = 0. 56), P-amp-
mean (p = 0.18), P-area-mean (p = 0.054), P-d (p = 0.4), P-max (p = 0.051), and P-du-SD (p = 
013), were noted in the patients with PERE and the "controls" on admission;1  however heart 
rates were faster (p = 0.002), and P-R intervals were shorter (p = 0.007), P-du-mean, (p=0.003), 
and P-min (p = 0.047) were shorter in patients with PERED (Tables 1 and 2). Electrolytes in 
patients with PERED were unchanged. 
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Table 1. P-wave measurements on admission, peak weight, and subsequent lowest weight in 
patients developing PERED (N=16) and (N = 6).
Abbreviations as in the text. The values under the 2 headings of "Peak weight" are 
different, because the first reflect all the patients (N = 16) and the second reflect the sub-
fraction of patients (N=6), who subsequently lost weight. Results above the line represent 
data published previously (with permission from the Madias JE. P-waves in patients with 
changing edematous states: Implications on interpreting repeat P-wave measurements in 
patients developing anasarca or undergoing hemodialysis. Pacing and Clin Electrophysiol 
2004;27:749-56., Blackwell Publishing), and are included here to facilitate interpretation 
of the data of the present study. 
Table 2.   P-wave measurements on admission and discharge of "controls" (N=20) 
Abbreviations as in the text. Results above the line represent data published previously 
(with permission from the Madias JE. P-waves in patients with changing edematous 
states: Implications on interpreting repeat P-wave measurements in patients developing 
anasarca or undergoing hemodialysis. Pacing and Clin Electrophysiol 2004;27:749-56., 
Blackwell Publishing), and are included here to facilitate interpretation of the data of the 
present study. 
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Manual vs. automated measurements in patients with PERED                               
            Correlation of automated P-amp-mean and manual ΣP was significant (r = 62, p =0.01). 
Comparing the manual and automated measurements of the amplitude of P-waves (multiplying 
the latter by 12) on Table 1, it appears that manual measurements underestimated the P-wave 
amplitude at the time of peak weight gain, for the 16 patients with PERED and the 6 patients 
who lost weight, and overestimated it at the time of the lowest weight. P-amp-mean decreased at 
the time of peak weight and increased at the time of weight loss (Table 1), as noted previously 
with manual measurements (ΣP).1                                                                                        
Manual vs. automated measurements in "controls"                                                                      
            Correlation of the automated P-amp-mean and the manual ΣP1 in the "controls" was 
excellent on admission (r = 0.91, p = 0.00005), and at discharge (r = 0.94, p = 0.00005). 
Comparison of the values of ΣP to the P-amp-mean (multiplying the latter by 12) on Table 2 
reveals the agreement of the amplitudes of P-waves derived by the 2 methods.                      
Correlations of patients with PERED                                                                               
     
            Correlation of the change in the automated P-amp-mean and peak weight gain (r = 0.80, 
p =0.0002) for the patients with PERED was good; however such correlations were poor for the 
patients who lost weight, at their peak weight (r = 0.55, p = 0.26), and subsequent lowest weight 
(r = 0.75, p = 0.09) (Table 1). P-area-mean at baseline, peak weight, and lowest weight followed 
the same pattern as the P-amp-mean (Table 1). On the other hand the 4 parameters reflecting P-
duration, the P-d, and the P-horiz-axis did not change with the fluid perturbations (Table 1). The 
behavior   of   P-horiz-axis   corroborated   the   previous   findings   on   P-fro-axis.1 
Comparisons   in   "controls"                                                                          
            All P-wave and other parameters in the 20 "controls" did not change between admission 
and discharge, save for the P-area-mean, which decreased at discharge in comparison with 
admission  (Table 2).                                                                                            
                                               
Discussion
            Changes of P-du-mean and P-d have been observed in patients with PERED (e.g., treated 
for CHF or after HD),28-31  which suggest that PERED should be taken into account, when 
employing P-wave indices. Management of CHF by diuresis led to reduction of P-du-mean and 
P-max, with an inverse correlation between P-du-mean and fluid volume lost (r = -0.59, p = 
0.015),28 viewed as amelioration of electrophysiology disturbances, caused by volume overload. 
Also, signal averaged P-du, was longer in patients with higher pulmonary capillary wedge 
pressure, and reduction of the latter by nitroprusside, led to reduction of the P-du, although left 
atrial diameter did not correlate with P-du.29 In contrast, alleviation of fluid overload by HD 
resulted in lengthening of P-max and P-d (considered arrhythmogenic),30,31 and attributed to 
electrolyte imbalances, or the HD itself. Changes in the P-waves were more notable in patients 
with left atrial diameter >45 mm;30 also P-max and P-d correlated with biochemical parameters, 
effected by HD.31  The above P-wave changes are presumed to be  electrophysiologically-
mediated,   reflective   of   alterations   imparted   on   the   heart,   and   thought   to   have   clinical 
consequences.
            It is paradoxical that improvement of the fluid overload in patients with CHF and after 
HD produced divergent responses in the P-du and P-d. Furthermore, the present report showed 
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no changes in P-du-mean and P-d in patients with a variety of critical illnesses and marked 
PERED (Table 1). The reliability of this observation was strengthened by the stability of the P-
du-mean and P-d in patients with PERED who lost weight, (Table 1), and in the "controls", who 
had stable weights during hospital stay (Table 2). P-wave indices were unchanged throughout 
this study, in-spite of major perturbations of the degree of PERED of patients; also values of P-
wave parameters of PERED patients and the "controls" were similar to the ones described in 
previous studies;4-23 P-max and P-d of PERED patients and the "controls" were similar to the 
ones reported in patients with paroxysmal AF and large left atrial distensions, and higher than 
reported for subjects without history of cardiovascular illness.17,22 Values of P-max were higher 
for patients with CHF than the "controls" without known heart disease in a previous study, but 
such measurements were made by signal-averaged techniques.29 All the above suggest that the 
interplay of the P-du and P-d with PERED in patients with different illnesses may be complex. 
P-du-mean and P-d are impacted by changes in the preload and afterload,16,28,29  circadian 
variation,34 baseline left atrial dimension and its change, atrial stretch and its relief,29,39 age, the 
state   of   the   autonomic   nervous   system,40  and   concomitant   medications,40,41  all   with 
electrophysiological influence on the heart; however PERED and its partial reversal per se,  also 
may have an impact on P-wave indices. PERED due to CHF may be different from that 
associated with the multiple non-cardiac illnesses as included in the present study. One would 
expect atrial loading and P-wave parameters to be directly correlated with PERED in CHF, and 
thus induce electrophysiological derangements, but not so in pneumonia and other non-cardiac 
illnesses. At first glance the patients of the present study, which did not have CHF as an 
inclusion criterion, would not be expected to show correlation of P-wave changes with PERED. 
However these patients had history of hypertension, coronary artery disease, received large 
volumes of intravenous fluids, gained in turn enormous weights, developing "anasarca" PERED. 
In this respect the patients of this study should be considered as afflicted by both cardiac and 
non-cardiac illnesses. It is also possible that a more homogeneous group of patients might have 
shown different response to PERED, than shown in this patient cohort with diverse pathology. 
            When volume perturbations are implicated for the changes of P-wave indices in patients, 
it is meant implicitly or explicitly that the hemodynamic changes mediate electrophysiological 
alterations, expressed as prolongation in such indices.4-41 However this report aims at partially 
implicating the PERED per se, as a contributing non-electrophysiologic mechanism of changes 
in P-wave parameters. In such context P-waves undergo  apparent  (in contrast to real, i.e., 
electrophysiologically-mediated) alterations due to the changes in the electrical properties of the 
"passive" volume conductor surrounding the heart. There is literature showing increase in the 
QRS complexes after HD,42-46 decrease and increase in the amplitude of QRS complexes and P-
waves in patients with PERED and its amelioration,1,32  and augmentation of QRS complexes 
with management of patients with CHF.47-49  Commensurate with attenuation of the QRS 
complexes with PERED, reversible shortening of the QRS duration has been observed,2,50 which 
is not viewed as real (i.e., change in the ventricular conduction velocity and the duration of 
depolarization), but as apparent, resulting from failure of the measurement at the onset and 
offset of the QRS complexes, by which these portions of the QRS complexes are so low as to be 
indistinguishable from "noise", or are below the threshold of potential detection of the measuring 
algorithm.2 By analogy one can envisage similar apparent changes in the P-du-mean and P-d, 
since the effect of the edematous body conductor is exerted proportionally on all components of 
the ECG curve, QRS complexes and P-waves alike.1,32 An extreme precedent exists in the virtual 
disappearance of P-waves in patients with PERED where there are no detectable P-waves by 
either visual inspection, or by the automation a diagnosis of "junctional rhythm", is made, while 
intracardiac ECG reveals the presence of P-waves.51 The effect of the gain/loss of excessive 
fluid in the "passive" body volume conductor has been discussed in detail elsewhere,1,32 and it 
leads to a decrease/increase in the "composite impedance" due to gain/loss of a constituent 
(water) with the lowest resistivity in the body,52 thus resulting in attenuation/augmentation of 
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potentials of the entire PQRSTU ECG curve, and as per Ohm's law (V = I x R, where V = 
voltage, I = current, and R = resistance).53-57                                                                   
            The above formulation does not imply that all the other known influences were not 
exerted in our patients with PERED. The edematous state produced reversible attenuation of the 
ΣP, P-amp-mean, and P-area-mean1 (Table 1); however P-du-mean and all the other associated 
parameters did not change, as also noted in the "controls" who did not experience any changes in 
their body weights. These patients received large fluid volumes, suffered pneumonia and sepsis, 
were intubated, and developed acute renal failure,1,32  all conditions expecting to lead to 
prolongation of P-du-mean and P-d. Plausible explanations for the reduction of P-amp-mean, ΣP 
and P-area-mean, with unaltered P-durations are: 1) No changes in the P-durations occurred 
(Figure 3A), in-spite of the changes in P-wave amplitudes and areas. 2) Hemodynamic and or 
other electrophysiological influences leading to prolongation of the P-wave duration were 
exerted (Figure 3C), but they were counteracted by the shortening of the P-duration effect of 
PERED (Figure 3B), producing a cancellation effect (Figure 3D), and leading to an unchanged 
P-du-mean and P-d (Figure 3A  and  3D). In short, it is proposed herein that the apparent 
influence of PERED has cancelled out the electrophysiologically-mediated real changes. 
Figure 3:  Hypothetical cardiac and extracardiac influences on the P-wave duration. 
               Measurements in this study were automation-based, and although they were used 
uniformly in all the patients with PERED and all the "controls", and for all 3 phases of the study, 
this constitutes a limitation of this work. However the automation system implemented has been 
previously repeatedly validated.35,36 One should also keep in mind that particularly when the P-
wave duration is the focus of an investigation, even manual measurements of magnified analog 
ECG tracings, or computer-based measurements with electronic calipers and operator input, are 
not devoid of difficulties, ambivalence, and uncertainty, as to where exactly is the onset and 
offset of P-waves.
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